Inside Venture Decision-Making Across AI, Deep Tech, and Biotech

This upcoming episode of The David Daily focuses on how venture capital decision-making is evolving across AI, deep tech, and biotech, and what founders and operators need to understand about the next investment cycle.I’m joined by Scott Chou, venture investor, advisor, and author of Maxims, Morals, and Metaphors, a sharp and insightful take on the realities of venture capital. Scott brings a unique perspective shaped by hands-on experience across early-stage investing, innovative financing structures, and advising funds focused on AI, security, and advanced technology.In this conversation, we’ll break down how VCs actually evaluate deal flow across fast-moving markets like artificial intelligence, deep tech, and biotech. Scott shares how conviction, judgment, and responsibility factor into investment decisions when technology cycles move faster than traditional capital frameworks. We’ll also explore the signals investors are watching right now as AI, deep tech, and biotech reshape the next wave of innovation and capital deployment.This episode is designed for founders, operators, and investors who want a clearer view into how venture firms think, how decisions get made under uncertainty, and how emerging technology trends are influencing the next investment cycle.Topics covered in this episode:1. How VCs Evaluate Deal Flow Across AI, Deep Tech, and Biotech Markets2. Decision-Making, Conviction, and Responsibility in High-Velocity Tech Investing3. AI, Deep Tech, and Biotech Trends Shaping the Next Investment CycleTune in for insight, perspective, and thoughtful conversation on technology, capital, and leadership.Powered by Reveting